Metabolic tumour volume as prognostic factor for early response to treatment in advanced stage Hodgkin lymphoma

被引：0
|
作者：
Kreissl, S. [1 ,2 ]
Mueller, H. [2 ]
Voltin, C. -A. [3 ]
Baues, C. [2 ,4 ]
Klaeser, B. [5 ]
Moccia, A. [6 ,7 ]
Borchmann, P. [1 ,2 ]
Engert, A. [1 ,2 ]
Kuhnert, G. [3 ]
Drzezga, A. [3 ]
Dietlein, M. [2 ,3 ]
Kobe, C. [2 ,3 ]
Mettler, J. [2 ,3 ]
机构：
[1] Uniklin Koln, Innere Med 1, Cologne, Germany
[2] German Hodgkin Study Grp GHSG, Cologne, Germany
[3] Uniklin Koln, Abt Nukl Med, Cologne, Germany
[4] Uniklin Koln, Abt Strahlentherapie, Cologne, Germany
[5] Bern Univ Hosp, Inselspital, Bern, Switzerland
[6] Oncol Inst Southern Switzerland, Med Onkol, Bellinzona, Switzerland
[7] Swiss Grp Clin Canc Res, Bern, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P432
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [31] Metabolic tumor volume as an independent prognostic factor in lymphoma.
    Grow, A
    Quon, A
    Graves, EE
    Loo, BW
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 583S - 583S
  • [32] A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?
    Longo, Dan L.
    Armitage, James O.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (04): : 370 - 372
  • [33] Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma
    Rautert, Roger
    Schinkothe, Timo
    Franklin, Jeremy
    Weihrauch, Martin
    Boell, Boris
    Pogge, Elke
    Bredenfeld, Henning
    Engert, Andreas
    Diehl, Volker
    Re, Daniel
    LEUKEMIA & LYMPHOMA, 2008, 49 (11) : 2091 - 2098
  • [34] Analysis of prognostic factors in childhood advanced stage Hodgkin lymphoma: A retrospective study
    Dongre, Arnol Shankar
    Arora, Brijesh
    Banavali, Shripad Dinanath
    Gulia, Seema
    Leakar, Siddarth
    Shet, Tanuja
    Kembhavl, Seema
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma
    Jakovic, Ljubomir R.
    Mihaljevic, Biljana S.
    Jovanovic, Maja D. Perunicic
    Bogdanovic, Andrija D.
    Andjelic, Bosko M.
    Bumbasirevic, Vladimir Z.
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1913 - 1919
  • [36] Managing advanced stage Hodgkin lymphoma
    Saikia, T. K.
    JOURNAL OF POSTGRADUATE MEDICINE, 2015, 61 (02) : 75 - 76
  • [37] Advanced-stage Hodgkin lymphoma
    Ferdinandus, J.
    Oertel, M.
    Eichenauer, D. A.
    Meissner, J.
    Engert, A.
    Borchmann, P.
    ONKOLOGIE, 2022, 28 (10): : 889 - 900
  • [38] Tumour volume as a prognostic marker in early-stage nasopharyngeal carcinoma
    Poh, S.
    Mueller, S.
    Lam, W.
    Teo, P.
    Tan, H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S625 - S625
  • [39] Controversies in the Treatment of Early-Stage Hodgkin's Lymphoma
    Longo, Dan L.
    Armitage, James O.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (17): : 1667 - 1669
  • [40] Controversies in the treatment of early and intermediate stage Hodgkin's lymphoma
    Sasse, S.
    Behringer, K.
    Semrau, R.
    Engert, A.
    ONKOLOGE, 2014, 20 (05): : 448 - +
12345